Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix

Author's Avatar
Mar 07, 2022

%3Cb%3EBone+Biologics+Corporation%3C%2Fb%3E (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces it has entered into a supply agreement with MTF Biologics for demineralized bone matrix (DBM). MTF Biologics is a global nonprofit organization that provides one of the orthopedic industry’s largest portfolios of allograft tissue.